Manufacturer record
Healer's Lab Unit II: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
35 batches manufactured by Healer's Lab Unit II (Himachal Pradesh) were declared Not of Standard Quality between June 2022 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: PAK-815, Paracetamol Tablets IP 500 mg (exp Oct 2027). DTL, Thrissur (state lab) found it not of standard quality: The Sample does not conform to IP standards with respect to the test Dissolution. Listed in the September 2026 alert.
Records by type
35 records linked to Healer's Lab Unit II in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
0Banned or prohibited
0Recalled or suspended
35Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
35
NSQ batches since 2022
9
Products affected
Dissolution
Most common failure
Sep 2026
Latest alert
Flagged batches per year
2022 · 22025 · 62026 · 27
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Paracetamol Tablets IP 500 mg | Batch PAK-815Mfg Nov 2024 · Exp Oct 2027 | The Sample does not conform to IP standards with respect to the test Dissolution.Dissolution | DTL, ThrissurState lab | Sep 2026 |
| Ferrous ascorbate & folic acid tablet IP (100mg/1.5mg) | Batch FAM-647Mfg May 2025 · Exp Oct 2026 | Description (Cracking)Description | DTL Bhopal,Madhya PradeshState lab | Sep 2026 |
| Ferrous ascorbate & folic acid tablet IP (100mg/1.5mg) | Batch FAM-646Mfg May 2025 · Exp Oct 2026 | Description (Cracking)Description | DTL Bhopal,Madhya PradeshState lab | Sep 2026 |
| Ferrous ascorbate & folic acid tablet IP (100mg/1.5mg) | Batch FAM-643Mfg May 2025 · Exp Oct 2026 | Description (Cracking)Description | DTL Bhopal,Madhya PradeshState lab | Sep 2026 |
| Ferrous ascorbate & folic acid tablet IP (100mg/1.5mg) | Batch FAM-648Mfg May 2025 · Exp Oct 2026 | Description (Cracking)Description | DTL Bhopal,Madhya PradeshState lab | Sep 2026 |
| Vildagliptin Tablets IP 50 mg | Batch VGT-509Mfg Nov 2025 · Exp Oct 2027 | Content- ViladagliptinOther | DTL, Madurai-19State lab | Aug 2026 |
| Paracetamol Tablets IP 500 mg | Batch PAK-758Mfg Jul 2024 · Exp Jun 2027 | The sample does not conform to IP standards with respect to the test DissolutionDissolution | DTL, ThrissurState lab | Aug 2026 |
| Paracetamol Tablets IP 500 mg | Batch PAK-584Mfg Nov 2023 · Exp Oct 2026 | The sample does not conform to IP standards with respect to the test Dissolution. The sample shows category B defects of tablets (presence of dark brown colour spots) as described under DCC Guidelines on NSQ Drugs approved in 1993.Dissolution | DTL, ThrissurState lab | Aug 2026 |
| Paracetamol Tablets IP 500 mg | Batch PAK-637Mfg Feb 2024 · Exp Jan 2027 | The sample does not conform to IP standards with respect to the test Dissolution. The sample shows category B defects of tablets (presence of dark brown colour spots) as described under DCC Guidelines on NSQ Drugs approved in 1993.Dissolution | DTL, ThrissurState lab | Aug 2026 |
| Paracetamol Tablets IP 500 mg | Batch PAK-636Mfg Feb 2024 · Exp Jan 2027 | The sample does not conform to the IP standards with respect to the test Dissolution. The sample shows category B defects of tablets (Presence of spots) as described under DCC Guidelines on NSQ Drugs approved in 1993Dissolution | DTL, ThrissurState lab | Aug 2026 |
| Clopidogrel Tablets IP 75mg | Batch CPT-508Mfg Jan 2026 · Exp Dec 2027 | DescriptionDescription | DTL, Chennai-06State lab | Aug 2026 |
| Paracetamol Tablets IP 500 mg | Batch PAK-825Mfg Jan 2025 · Exp Dec 2027 | The sample does not conform to the IP standards with respect to the test for DissolutionDissolution | DTL, ThrissurState lab | Jul 2026 |
| Ferrous Ascorbate & Folic Acid Tablets IP | Batch FAM-677Mfg Aug 2025 · Exp Jan 2027 | NSQOther | DTL BhopalState lab | Jul 2026 |
| Ferrous Ascorbate & Folic Acid Tablets IP | Batch FAM-656Mfg Aug 2025 · Exp Jan 2027 | NSQOther | DTL BhopalState lab | Jul 2026 |
| Ferrous Ascorbate & Folic Acid Tablets IP | Batch FAM-629Mfg May 2025 · Exp Oct 2026 | NSQOther | DTL BhopalState lab | Jul 2026 |
| Ferrous Ascorbate & Folic Acid Tablets IP | Batch FAM-649Mfg May 2025 · Exp Oct 2026 | NSQOther | DTL BhopalState lab | Jul 2026 |
| Ferrous Ascorbate & Folic Acid Tablets IP | Batch FAM-628Mfg May 2025 · Exp Oct 2026 | NSQOther | DTL BhopalState lab | Jul 2026 |
| Paracetamol Tablets IP 500mg | Batch PAK-752Mfg Jul 2024 · Exp Jun 2027 | The sample does not conform to IP standards. It fails the test Dissolution and Description' mentioned in the laboratory protocol as per IPDissolution | DTL, KonniState lab | Jun 2026 |
| Paracetamol Tablets IP 500mg | Batch PAK-619Mfg Jan 2024 · Exp Dec 2026 | The sample does not conform to IP standards. It fails the test Dissolution and Description mentioned in the laboratory protocol as per IPDissolution | DTL, KonniState lab | Jun 2026 |
| Paracetamol Tablets IP 500 mg | Batch PAK-643Mfg Feb 2024 · Exp Jan 2027 | Sample does not conform to IP 2022 standards. This particular batch sample fails the test DissolutionDissolution | RDTL, ErnakulamState lab | Jun 2026 |
| Paracetamol Tablets IP 500 mg | Batch PAK-628Mfg Jan 2024 · Exp Dec 2026 | It fails the test Dissolution as per IP as specified in the Laboratory Protocol.Dissolution | DTL, TVPMState lab | Jun 2026 |
| Paracetamol Tablets IP 500 mg | Batch PAK-557Mfg Sep 2023 · Exp Aug 2026 | The sample does not conform to IP standards. It fails the test Dissolution.Dissolution | DTL, KonniState lab | Jun 2026 |
| Drotaverine Hydrochloride & Mefenamic Acid Tablets | Batch DMR-504Mfg Jan 2026 · Exp Dec 2027 | The sample does not conforms to the claim with respect to description as it show physical instability in the form of Mottling.Description | DTL, UdaipurState lab | Jun 2026 |
| Paracetamol Tablets IP 500mg | Batch PTT-512Mfg Apr 2025 · Exp Mar 2028 | DissolutionDissolution | DTL, Chennai-06State lab | May 2026 |
| Paracetamol Tablets IP 500mg | Batch PAK-634Mfg Jan 2024 · Exp Dec 2026 | Dissolution as per IPDissolution | RDTL, ErnakulamState lab | Mar 2026 |
| Vildagliptin Tablets IP 50mg | Batch VGT505Mfg Jun 2025 · Exp May 2027 | ContentOther | DTL, Madurai-19State lab | Feb 2026 |
| Paracetamol Tablets IP 500mg | Batch PAK-632Mfg Jan 2024 · Exp Dec 2026 | sample fails the test "Dissolution" as per IPDissolution | DTL ThrissurState lab | Jan 2026 |
| Aceclofenac & Paracetamol Tablets IP 100 mg /325 mg | Batch APC-508Mfg Jul 2024 · Exp Jun 2026 | AssayAssay | SDTL Raipur ChhattisgarhState lab | Aug 2025 |
| Levocetirizine Dihydrochloride Tablets IP 5 mg | Batch LLP-511Mfg Dec 2023 · Exp Nov 2025 | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua, Jammu and KashmirState lab | Jul 2025 |
| Paracetamol Tablets IP 500 mg | Batch PAK-517Mfg May 2023 · Exp Apr 2026 | It fails the test for ?Dissolution? as per IP as Specified in the laboratory protocolDissolution | DTL ThiruvananthapuramState lab | Apr 2025 |
| Paracetamol Tab IP 500 mg | Batch PAK-558Mfg Sep 2023 · Exp Aug 2026 | It fails the test ?Dissolution? as per IP, as Specified in the laboratory protocolDissolution | DTL ThiruvananthapuramState lab | Apr 2025 |
| Paracetamol Tab IP 500 mg | Batch PAK-524Mfg May 2023 · Exp Apr 2026 | It fails the test ?Dissolution? as per IP specified in the laboratory protocolDissolution | DTL ThiruvananthapuramState lab | Apr 2025 |
| Paracetamol Tab IP 500 mg | Batch PAK 551Mfg Jun 2023 · Exp May 2026 | It fails the test ?Dissolution? Specified in the laboratory protocol as per IPDissolution | DTL ThiruvananthapuramState lab | Feb 2025 |
| Rabeprazole Sodium Tablets I.P. | Batch RBM-501Mfg Apr 2022 · Exp Mar 2024 | AssayAssay | CDTL MumbaiCDSCO lab | Nov 2022 |
| Albendazole Tablets I.P. | Batch ALO-522Mfg Jan 2021 · Exp Dec 2022 | DescriptionDescription | CDL KolkataCDSCO lab | Jun 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.